Clinical Trials Browser

Phase 2 × Carcinoma, Endometrioid × copanlisib × Clear all

NCT02728258 2022-02-15

Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Phase 2 Completed

11 enrolled 12 charts

Carcinoma, Endometrioid